tiprankstipranks
Boston Scientific (DE:BSX)
XETRA:BSX
Germany Market
BSX
Boston Scientific
RESEARCH TOOLSreports

Boston Scientific (BSX) Stock Forecast & Price Target

12 Followers
See the Price Targets and Ratings of:

BSX Analyst Ratings

Strong Buy
22Ratings
Strong Buy
20 Buy
2 Hold
0 Sell
Based on 22 analysts giving stock ratings to
Boston
Scientific
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BSX Stock 12 Month Forecast

Average Price Target

€52.36
▲(29.12% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is €52.36 with a high forecast of €72.96 and a low forecast of €42.92. The average price target represents a 29.12% change from the last price of €40.55.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"36":"€36","63":"€63","90":"€90","49.5":"€49.5","76.5":"€76.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":72.9606221,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€72.96</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.35997586,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€52.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42.918013,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€42.92</span>\n  </div></div>","useHTML":true}}],"tickPositions":[36,49.5,63,76.5,90],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.18,41.77850939230769,44.37701878461539,46.97552817692308,49.57403756923077,52.17254696153846,54.77105635384615,57.369565746153846,59.968075138461536,62.56658453076923,65.16509392307692,67.76360331538461,70.3621127076923,{"y":72.9606221,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.18,40.193844296923075,41.20768859384615,42.22153289076923,43.23537718769231,44.24922148461538,45.26306578153846,46.27691007846154,47.290754375384616,48.30459867230769,49.318442969230766,50.33228726615384,51.34613156307692,{"y":52.35997586,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.18,39.467539461538465,39.75507892307692,40.04261838461539,40.330157846153845,40.61769730769231,40.90523676923077,41.19277623076923,41.48031569230769,41.767855153846156,42.055394615384614,42.34293407692308,42.630473538461544,{"y":42.918013,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":89.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 86,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.2,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 97,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.62,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 88,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.175,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 70,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.685,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.18,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€72.96Average Price Target€52.36Lowest Price Target€42.92
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on DE:BSX
Josh Jennings
TD Cowen
TD Cowen
€48.07
Buy
18.54%
Upside
Reiterated
08/28/26
Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX) and Eli Lilly & Co (NYSE: LLY)
Truist Financial Analyst forecast on DE:BSX
Richard Newitter
Truist Financial
Truist Financial
―
Buy
―
Reiterated
08/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: P3 Health Partners (NASDAQ: PIII) and Boston Scientific (NYSE: BSX)
Jefferies Analyst forecast on DE:BSX
Matthew Taylor
Jefferies
Jefferies
€51.5
Buy
27.01%
Upside
Assigned
08/21/26
Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (NASDAQ: EVAX) and Boston Scientific (NYSE: BSX)
Citi Analyst forecast on DE:BSX
Joanne Wuensch
Citi
Citi
€52.36
Buy
29.12%
Upside
Reiterated
08/13/26
Citi Keeps Their Buy Rating on Boston Scientific (BSX)
Bank of America Securities Analyst forecast on DE:BSX
Travis Steed
Bank of America Securities
Bank of America Securities
€17.17→€46.35
Buy
14.31%
Upside
Reiterated
08/11/26
Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)
Mizuho Securities Analyst forecast on DE:BSX
Anthony Petrone
Mizuho Securities
Mizuho Securities
€60.09→€51.5
Buy
27.01%
Upside
Reiterated
07/31/26
Mizuho Securities Remains a Buy on Boston Scientific (BSX)
Argus Research Analyst forecast on DE:BSX
David Toung
Argus Research
Argus Research
―
Hold
―
Downgraded
07/30/26
Boston Scientific downgraded to Hold from Buy at ArgusBoston Scientific downgraded to Hold from Buy at Argus
Deutsche Bank Analyst forecast on DE:BSX
Pito Chickering
Deutsche Bank
Deutsche Bank
€64.38→€51.5
Buy
27.01%
Upside
Reiterated
07/30/26
Deutsche Bank Remains a Buy on Boston Scientific (BSX)
Oppenheimer Analyst forecast on DE:BSX
Suraj Kalia
Oppenheimer
Oppenheimer
€72.96
Buy
79.93%
Upside
Reiterated
07/30/26
Oppenheimer Keeps Their Buy Rating on Boston Scientific (BSX)
Leerink Partners Analyst forecast on DE:BSX
Mike Kratky
Leerink Partners
Leerink Partners
€63.52→€51.5
Buy
27.01%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $60 from $74 at LeerinkBoston Scientific price target lowered to $60 from $74 at Leerink
Evercore ISI Analyst forecast on DE:BSX
Vijay Kumar
Evercore ISI
Evercore ISI
€55.79→€47.21
Buy
16.42%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $55 from $65 at Evercore ISIBoston Scientific price target lowered to $55 from $65 at Evercore ISI
J.P. Morgan Analyst forecast on DE:BSX
Robbie Marcus
J.P. Morgan
J.P. Morgan
€68.67→€48.07
Buy
18.54%
Upside
Assigned
07/30/26
Boston Scientific price target lowered to $56 from $80 at JPMorganBoston Scientific price target lowered to $56 from $80 at JPMorgan
Canaccord Genuity Analyst forecast on DE:BSX
William Plovanic
Canaccord Genuity
Canaccord Genuity
€60.09→€56.65
Buy
39.71%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $66 from $70 at CanaccordBoston Scientific price target lowered to $66 from $70 at Canaccord
Robert W. Baird Analyst forecast on DE:BSX
David Rescott
Robert W. Baird
Robert W. Baird
€54.94→€48.07
Buy
18.54%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $56 from $64 at BairdBoston Scientific price target lowered to $56 from $64 at Baird
UBS Analyst forecast on DE:BSX
Patrick Wood
UBS
UBS
€63.52→€57.51
Buy
41.83%
Upside
Reiterated
07/30/26
Morgan Stanley Reaffirms Their Buy Rating on Boston Scientific (BSX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on DE:BSX
Josh Jennings
TD Cowen
TD Cowen
€48.07
Buy
18.54%
Upside
Reiterated
08/28/26
Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX) and Eli Lilly & Co (NYSE: LLY)
Truist Financial Analyst forecast on DE:BSX
Richard Newitter
Truist Financial
Truist Financial
―
Buy
―
Reiterated
08/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: P3 Health Partners (NASDAQ: PIII) and Boston Scientific (NYSE: BSX)
Jefferies Analyst forecast on DE:BSX
Matthew Taylor
Jefferies
Jefferies
€51.5
Buy
27.01%
Upside
Assigned
08/21/26
Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (NASDAQ: EVAX) and Boston Scientific (NYSE: BSX)
Citi Analyst forecast on DE:BSX
Joanne Wuensch
Citi
Citi
€52.36
Buy
29.12%
Upside
Reiterated
08/13/26
Citi Keeps Their Buy Rating on Boston Scientific (BSX)
Bank of America Securities Analyst forecast on DE:BSX
Travis Steed
Bank of America Securities
Bank of America Securities
€17.17→€46.35
Buy
14.31%
Upside
Reiterated
08/11/26
Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)
Mizuho Securities Analyst forecast on DE:BSX
Anthony Petrone
Mizuho Securities
Mizuho Securities
€60.09→€51.5
Buy
27.01%
Upside
Reiterated
07/31/26
Mizuho Securities Remains a Buy on Boston Scientific (BSX)
Argus Research Analyst forecast on DE:BSX
David Toung
Argus Research
Argus Research
―
Hold
―
Downgraded
07/30/26
Boston Scientific downgraded to Hold from Buy at ArgusBoston Scientific downgraded to Hold from Buy at Argus
Deutsche Bank Analyst forecast on DE:BSX
Pito Chickering
Deutsche Bank
Deutsche Bank
€64.38→€51.5
Buy
27.01%
Upside
Reiterated
07/30/26
Deutsche Bank Remains a Buy on Boston Scientific (BSX)
Oppenheimer Analyst forecast on DE:BSX
Suraj Kalia
Oppenheimer
Oppenheimer
€72.96
Buy
79.93%
Upside
Reiterated
07/30/26
Oppenheimer Keeps Their Buy Rating on Boston Scientific (BSX)
Leerink Partners Analyst forecast on DE:BSX
Mike Kratky
Leerink Partners
Leerink Partners
€63.52→€51.5
Buy
27.01%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $60 from $74 at LeerinkBoston Scientific price target lowered to $60 from $74 at Leerink
Evercore ISI Analyst forecast on DE:BSX
Vijay Kumar
Evercore ISI
Evercore ISI
€55.79→€47.21
Buy
16.42%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $55 from $65 at Evercore ISIBoston Scientific price target lowered to $55 from $65 at Evercore ISI
J.P. Morgan Analyst forecast on DE:BSX
Robbie Marcus
J.P. Morgan
J.P. Morgan
€68.67→€48.07
Buy
18.54%
Upside
Assigned
07/30/26
Boston Scientific price target lowered to $56 from $80 at JPMorganBoston Scientific price target lowered to $56 from $80 at JPMorgan
Canaccord Genuity Analyst forecast on DE:BSX
William Plovanic
Canaccord Genuity
Canaccord Genuity
€60.09→€56.65
Buy
39.71%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $66 from $70 at CanaccordBoston Scientific price target lowered to $66 from $70 at Canaccord
Robert W. Baird Analyst forecast on DE:BSX
David Rescott
Robert W. Baird
Robert W. Baird
€54.94→€48.07
Buy
18.54%
Upside
Reiterated
07/30/26
Boston Scientific price target lowered to $56 from $64 at BairdBoston Scientific price target lowered to $56 from $64 at Baird
UBS Analyst forecast on DE:BSX
Patrick Wood
UBS
UBS
€63.52→€57.51
Buy
41.83%
Upside
Reiterated
07/30/26
Morgan Stanley Reaffirms Their Buy Rating on Boston Scientific (BSX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Boston Scientific

3 Months
Marie ThibaultBTIG
Success Rate
27/40 ratings generated profit
68%
Average Return
+1.93%
Copying Marie Thibault's trades and holding each position for 3 Months would result in 67.50% of your transactions generating a profit, with an average return of +1.93% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
39/53 ratings generated profit
74%
Average Return
+12.21%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 73.58% of your transactions generating a profit, with an average return of +12.21% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
41/53 ratings generated profit
77%
Average Return
+22.97%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.36% of your transactions generating a profit, with an average return of +22.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BSX Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
30
36
25
18
8
Buy
67
52
45
47
39
Hold
1
3
3
4
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
98
91
73
69
49
In the current month, BSX has received 47 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 52.36.
Each month's total comprises the sum of three months' worth of ratings.

BSX Financial Forecast

BSX Earnings Forecast

Next quarter’s earnings estimate for BSX is €0.69 with a range of €0.68 to €0.72. The previous quarter’s EPS was €0.74. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s earnings estimate for BSX is €0.69 with a range of €0.68 to €0.72. The previous quarter’s EPS was €0.74. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Sales Forecast

Next quarter’s sales forecast for BSX is €4.50B with a range of €4.45B to €4.54B. The previous quarter’s sales results were €4.66B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s sales forecast for BSX is €4.50B with a range of €4.45B to €4.54B. The previous quarter’s sales results were €4.66B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Stock Forecast FAQ

What is DE:BSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Boston Scientific’s 12-month average price target is 52.36.
    What is DE:BSX’s upside potential, based on the analysts’ average price target?
    Boston Scientific has 29.12% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Boston Scientific a Buy, Sell or Hold?
          Boston Scientific has a consensus rating of Strong Buy, which is based on 20 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Boston Scientific’s share price target?
            The average share price target for Boston Scientific is 52.36. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €72.96 ,and the lowest forecast is €42.92. The average share price target represents 29.12% Increase from the current price of €40.55.
              What do analysts say about Boston Scientific?
              Boston Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of Boston Scientific?
                To buy shares of DE:BSX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.